filmov
tv
Mindset Pharma
0:06:22
Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering
0:04:16
Mindset Pharma to move forward with its psilocybin-based compound named MSP-1014
0:06:44
Mindset Pharma 'excited' by recent, positive findings on its DMT-inspired chemicals
0:14:05
Mindset Pharma | New Patents and a Message to Psychedelic Investors (CSE:MSET)
0:00:58
'Do Shrooms Make You COLD?' w/ Mindset Pharma's CSO Joseph Araujo @ Psychedelic Capital Aug '21
0:07:18
Mindset Pharma develops rodent studies to differentiate between psychedelic and non-psychedelics
0:31:34
Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)
0:07:54
Creating a quality mindset at a global pharma company
0:04:02
Mindset Pharma strengthens IP portfolio with new provisional patent application
0:45:59
Investment Spotlight: Mindset Pharma with James Lanthier
0:05:17
Mindset says new collab with Otsuka is 'first' Big Pharma and psychedelic partnership
0:12:55
Psychedelic Stocks in Focus | Business Update: James Lanthier, CEO of Mindset Pharma
0:09:19
Mindset Pharma inks agreement to begin collaborating with Global Neuroscience Pharmaceutical Giant !
0:04:50
Mindset Pharma say latest results further validate lead candidate's comparison to psilocybin
0:08:51
Greenshoe Minute - Mindset Pharma Inc. (MSET:CSE)
0:20:14
High Growth Stock to Watch | Cheap Biotech Stock | Stock News Today | Mindset Pharma | MSET
0:21:01
Mindset CEO Reveals His Strategy - Trade To Black #12
0:05:15
Mindset adds to IP portfolio with three non-tryptamine families of next-gen psychedelic compounds
0:02:46
Get Your Company Into the Quality Mindset | Pharma Biotech
0:42:06
Psychedelic Therapy: Joseph Araujo, Cofounder & Chief Scientific Officer, Mindset Pharma
0:05:13
Mindset Pharma CEO says it has 'covered an enormous amount of ground' in its fiscal 2021
0:07:59
Mindset Pharma (OTC:MSSTF) Streetlight Equity Review
0:07:25
Mindset Pharma Halftime Report 2022
0:00:48
CSE Welcome Mindset Pharma Inc.-CSE:MSET
Назад
Вперёд